Testing pulsed electric field ablation for small lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have non-small cell lung cancer with tumors that are 3 cm or smaller and no more than 3 tumors.
- You are well enough to undergo anesthesia and the ablation procedure.
- You do not have serious bleeding problems or take blood thinners that cannot be stopped.
- You do not have severe heart or lung conditions that would make the procedure unsafe.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a wearable device that uses electric fields (called tumor treating fields) before surgery for early-stage non-small cell lung cancer. The goal is to see if it can help shrink the tumor and improve outcomes for patients.
This trial tests whether combining a tumor-destroying procedure (ablation) with immunotherapy (tislelizumab) and chemotherapy before surgery can improve outcomes for people with stage II-IIIB non-small cell lung cancer. The goal is to shrink the tumor and boost the immune system to fight the cancer more effectively.
This trial tests a new treatment that uses short electric pulses (pulsed electric field) to target and damage cancer cells in the esophagus. It is for people with advanced esophageal cancer that cannot be removed by surgery, and it aims to be safe and potentially shrink or slow the tumor.
This trial compares two types of radiofrequency ablation (a heat-based treatment) for early-stage lung cancer that is located in the outer parts of the lung. One approach uses a needle through the chest wall, the other uses a bronchoscope through the airways. The goal is to see which works better for people who cannot have surgery.
This study compares two ways to destroy early-stage lung cancer without surgery: one using a needle through the chest (CT-guided) and another using a thin tube through the mouth (bronchoscopy-guided). It might be an option if you have small, outer-edge lung cancer and cannot or prefer not to have surgery.
This study tests a new treatment that uses electric pulses to destroy early-stage lung tumors without surgery. It is for people who cannot have surgery or radiation, or who choose not to.
Hear when a new NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.